Agency Forms Undergoing Paperwork Reduction Act Review, 33297-33298 [2021-13436]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
or less in 12-point font, single-spaced.
NIOSH will not respond to individual
informational submissions nor publish
publicly a compendium of responses.
An informational submission in
response to this Notice does not create
any commitment on or behalf of CDC or
HHS to develop or pursue any program
or ideas discussed herein or related to
PPE use for underserved user
populations more generally.
Disclaimer and Important Notes
This Federal Register Notice is for
planning purposes; it does not
constitute a formal announcement for
comprehensive applications. In
accordance with Federal Acquisition
Regulation 48 CFR 15.201(e), responses
to this Notice are not offers and cannot
be accepted by the Government to form
a binding award. NIOSH will not
provide reimbursement for costs
incurred in responding to this Notice.
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2021–13263 Filed 6–23–21; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–1266]
khammond on DSKJM1Z7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘HIV
prevention among Latina transgender
women who have sex with men:
Evaluation of a locally developed
intervention’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on February
25, 2021 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
HIV prevention among Latina
transgender women who have sex with
men: Evaluation of a locally developed
intervention (OMB Control No. 0920–
1266, Exp. 6/30/2021)—Revision—
National Center for HIV/AIDS, Viral
Hepatitis, STD and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS,
Viral Hepatitis, STD and TB Prevention
(NCHHSTP) is requesting approval for a
two-year extension of a currently
approved ICR (OMB Control No. 0920–
1266), titled ‘‘HIV prevention among
Latina transgender women who have
sex with men: Evaluation of a locally
developed intervention.’’ The goal of
this study is to evaluate the efficacy of
ChiCAS (Chicas Creando Acceso a la
Salud [Chicas: Girls Creating Access to
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
33297
Health]), a locally developed and
culturally congruent two-session
Spanish-language small-group
combination intervention, designed to
promote consistent condom use, and
access to, and participation in, preexposure prophylaxis (PrEP) and
medically supervised hormone therapy
by HIV seronegative Hispanic/Latina
transgender women who have sex with
men.
The information collected through
this study will be used to evaluate
whether the ChiCAS intervention is an
effective HIV-prevention strategy by
assessing whether exposure to the
intervention results in improvements in
participants’ health and HIV prevention
behaviors. The study will compare pre(baseline) and post-intervention (sixmonth) levels of HIV risk among
participants who have received the
intervention and participants who have
not yet received the intervention
(delayed-intervention group).
This study will be carried out in
metropolitan areas in and around North
Carolina, including Ashville, NC;
Charlotte, NC; Research Triangle
(metropolitan area of Greensboro,
Winston-Salem and High Point NC);
Raleigh, NC; Wilmington, NC; and
Greenville, SC. The study population
will include 140 HIV-negative Spanishspeaking transgender women.
Participants will be adults, at least 18
years of age, self-identify as male-tofemale transgender or report having
been born male and identifying as
female, and report having sex with at
least one man in the past six months.
We anticipate participants will be
comprised mainly of racial/ethnic
minority participants under 35 years of
age, consistent with the epidemiology of
HIV infection among transgender
women.
Intervention participants will be
recruited to the study through a
combination of approaches, including
traditional print advertisement, referral,
in-person outreach, and through word of
mouth. A quantitative assessment will
be used to collect information for this
study, which will be delivered at the
time of study enrollment, and again at
a six-month follow up. The assessment
will be used to measure differences in
sexual risk knowledge, perceptions and
behaviors including condom use, PrEP
use, and use of medically supervised
hormone therapy. Intervention
mediators, including healthcare
provider trust and communication
skills, self-reported health status and
healthcare access, community
attachment and social support will also
be measured. All participants will
complete an assessment at baseline and
E:\FR\FM\24JNN1.SGM
24JNN1
33298
Federal Register / Vol. 86, No. 119 / Thursday, June 24, 2021 / Notices
again at a six-month follow-up, after
enrolling in the study. The intervention
group will participate in ChiCAS after
completing the baseline assessment and
the delayed intervention group will
participate in ChiCAS after completing
the six-month follow up assessment.
CDC will also examine intervention
experiences through in-depth interviews
with 30 intervention group participants.
The interviews will capture
participants’ general experiences with
the ChiCAS intervention, as well as
their experiences and perceptions
specific to the main study outcomes:
PrEP knowledge, awareness, interest
and use; condom skills and use; and
hormone therapy knowledge,
awareness, interest and use.
It is expected that 50% of transgender
women screened will meet study
eligibility. We expect the initial
screening and contact information
gathering to take approximately four
minutes to complete. The baseline
assessment will take 60 minutes to
complete and will be administered to
140 participants. The follow up
assessment will take 45 minutes to
complete and will be administered to
140 participants one time. The
interview will take 90 minutes to
complete and will be administered to 30
participants from the intervention group
one time.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
155.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
General
General
General
General
General
Public—Adults
Public—Adults
Public—Adults
Public—Adults
Public—Adults
...................................
...................................
...................................
...................................
...................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–13436 Filed 6–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0604; Docket No. CDC–2021–
0057]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled ‘‘School-Associated Violent
Deaths Surveillance System (SAVD).’’
DATES: CDC must receive written
comments on or before August 23, 2021.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:19 Jun 23, 2021
Jkt 253001
Number of
respondents
Form name
Eligibility Screener ..........................................
Contact Information ........................................
Baseline Assessment .....................................
Follow-up Assessment ...................................
Interview .........................................................
You may submit comments,
identified by Docket No. CDC–2021–
0057 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffery M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
ADDRESSES:
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
140
70
70
70
15
Number of
responses per
respondent
1
1
1
1
1
Average
burden per
response
(in hours)
3/60
1/60
60/60
45/60
90/60
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
School Associated Violent Death
Surveillance System (OMB No. 0920–
0604, expiration 07/31/2022)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
E:\FR\FM\24JNN1.SGM
24JNN1
]]>Agencies
[Federal Register Volume 86, Number 119 (Thursday, June 24, 2021)]
[Notices]
[Pages 33297-33298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1266]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``HIV prevention among Latina transgender
women who have sex with men: Evaluation of a locally developed
intervention'' to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on February
25, 2021 to obtain comments from the public and affected agencies. CDC
received one comment related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
HIV prevention among Latina transgender women who have sex with
men: Evaluation of a locally developed intervention (OMB Control No.
0920-1266, Exp. 6/30/2021)--Revision--National Center for HIV/AIDS,
Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Center for HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP) is requesting approval for a two-year extension of
a currently approved ICR (OMB Control No. 0920-1266), titled ``HIV
prevention among Latina transgender women who have sex with men:
Evaluation of a locally developed intervention.'' The goal of this
study is to evaluate the efficacy of ChiCAS (Chicas Creando Acceso a la
Salud [Chicas: Girls Creating Access to Health]), a locally developed
and culturally congruent two-session Spanish-language small-group
combination intervention, designed to promote consistent condom use,
and access to, and participation in, pre-exposure prophylaxis (PrEP)
and medically supervised hormone therapy by HIV seronegative Hispanic/
Latina transgender women who have sex with men.
The information collected through this study will be used to
evaluate whether the ChiCAS intervention is an effective HIV-prevention
strategy by assessing whether exposure to the intervention results in
improvements in participants' health and HIV prevention behaviors. The
study will compare pre- (baseline) and post-intervention (six-month)
levels of HIV risk among participants who have received the
intervention and participants who have not yet received the
intervention (delayed-intervention group).
This study will be carried out in metropolitan areas in and around
North Carolina, including Ashville, NC; Charlotte, NC; Research
Triangle (metropolitan area of Greensboro, Winston-Salem and High Point
NC); Raleigh, NC; Wilmington, NC; and Greenville, SC. The study
population will include 140 HIV-negative Spanish-speaking transgender
women. Participants will be adults, at least 18 years of age, self-
identify as male-to-female transgender or report having been born male
and identifying as female, and report having sex with at least one man
in the past six months. We anticipate participants will be comprised
mainly of racial/ethnic minority participants under 35 years of age,
consistent with the epidemiology of HIV infection among transgender
women.
Intervention participants will be recruited to the study through a
combination of approaches, including traditional print advertisement,
referral, in-person outreach, and through word of mouth. A quantitative
assessment will be used to collect information for this study, which
will be delivered at the time of study enrollment, and again at a six-
month follow up. The assessment will be used to measure differences in
sexual risk knowledge, perceptions and behaviors including condom use,
PrEP use, and use of medically supervised hormone therapy. Intervention
mediators, including healthcare provider trust and communication
skills, self-reported health status and healthcare access, community
attachment and social support will also be measured. All participants
will complete an assessment at baseline and
[[Page 33298]]
again at a six-month follow-up, after enrolling in the study. The
intervention group will participate in ChiCAS after completing the
baseline assessment and the delayed intervention group will participate
in ChiCAS after completing the six-month follow up assessment.
CDC will also examine intervention experiences through in-depth
interviews with 30 intervention group participants. The interviews will
capture participants' general experiences with the ChiCAS intervention,
as well as their experiences and perceptions specific to the main study
outcomes: PrEP knowledge, awareness, interest and use; condom skills
and use; and hormone therapy knowledge, awareness, interest and use.
It is expected that 50% of transgender women screened will meet
study eligibility. We expect the initial screening and contact
information gathering to take approximately four minutes to complete.
The baseline assessment will take 60 minutes to complete and will be
administered to 140 participants. The follow up assessment will take 45
minutes to complete and will be administered to 140 participants one
time. The interview will take 90 minutes to complete and will be
administered to 30 participants from the intervention group one time.
There are no costs to the respondents other than their time. The
total estimated annualized burden hours are 155.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
General Public--Adults................ Eligibility Screener.... 140 1 3/60
General Public--Adults................ Contact Information..... 70 1 1/60
General Public--Adults................ Baseline Assessment..... 70 1 60/60
General Public--Adults................ Follow-up Assessment.... 70 1 45/60
General Public--Adults................ Interview............... 15 1 90/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-13436 Filed 6-23-21; 8:45 am]
BILLING CODE 4163-18-P
